Next Article in Journal
Spontaneous Resolution of Nitrofurantoin-Induced Chronic Pulmonary Toxicity Presenting with Respiratory Failure
Previous Article in Journal
Actively Caseating Endobronchial Tuberculosis Successfully Treated with Intermittent Chemotherapy without Corticosteroid: A Report of 2 Cases
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Diffuse Alveolar Haemorrhage Complicated by Pulmonary Embolism—Problems with Treatment

by
Justyna Fijołek
1,*,
Elzbieta Wiatr
1,
Lilia Jakubowska
2,
Malgorzata Polubiec-Kownacka
3,
Pawel Kuca
4 and
Kazimierz Roszkowski-Sliz
1
1
The Third Department of Pneumonology, National Research Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland
2
Department of Radiology, National Research Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
3
Department of Thoracic Surgery, Bronchoscopic Compartment, National Research Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
4
Cardio-Pulmonary Intensive Care Department, National Research Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2017, 85(6), 328-332; https://doi.org/10.5603/ARM.2017.0056
Submission received: 21 July 2017 / Revised: 18 October 2017 / Accepted: 18 October 2017 / Published: 13 December 2017

Abstract

Diffuse alveolar haemorrhage (DAH) refers to a clinical syndrome resulting from injury of the alveolar capillaries, arterioles and venules leading to red blood cel accumulation in the distal air spaces. The conditions associated with DAH and underlying disease determine the prognosis and the treatment regimen. The coexistence of DAH with venous thromboembolism (VTE) is a seroius problem for clinicians and poses a challenge in the therapeutic management. We describe a young patient who developed massive DAH in the course of anti-glomerular basement membrane (anti-GBM) disease (formerly called Goodpasture’s syndrome) complicated by pulmonary embolism (PE).
Keywords: alveolar hemorrhage; pulmonary embolism; treatment alveolar hemorrhage; pulmonary embolism; treatment

Share and Cite

MDPI and ACS Style

Fijołek, J.; Wiatr, E.; Jakubowska, L.; Polubiec-Kownacka, M.; Kuca, P.; Roszkowski-Sliz, K. Diffuse Alveolar Haemorrhage Complicated by Pulmonary Embolism—Problems with Treatment. Adv. Respir. Med. 2017, 85, 328-332. https://doi.org/10.5603/ARM.2017.0056

AMA Style

Fijołek J, Wiatr E, Jakubowska L, Polubiec-Kownacka M, Kuca P, Roszkowski-Sliz K. Diffuse Alveolar Haemorrhage Complicated by Pulmonary Embolism—Problems with Treatment. Advances in Respiratory Medicine. 2017; 85(6):328-332. https://doi.org/10.5603/ARM.2017.0056

Chicago/Turabian Style

Fijołek, Justyna, Elzbieta Wiatr, Lilia Jakubowska, Malgorzata Polubiec-Kownacka, Pawel Kuca, and Kazimierz Roszkowski-Sliz. 2017. "Diffuse Alveolar Haemorrhage Complicated by Pulmonary Embolism—Problems with Treatment" Advances in Respiratory Medicine 85, no. 6: 328-332. https://doi.org/10.5603/ARM.2017.0056

Article Metrics

Back to TopTop